

Is Prasugrel in shortage in 2026? Get the latest update on Prasugrel availability, cost, and what patients can do if they can't find it.
If you're having trouble filling your Prasugrel prescription, you're probably wondering: is there an actual shortage? The short answer is complicated. Let's break down what's happening with Prasugrel supply in 2026 and what it means for you.
As of early 2026, Prasugrel (brand name Effient) is not listed on the FDA Drug Shortage database or the ASHP (American Society of Health-System Pharmacists) shortage list. This means there is no formal, nationwide shortage declaration.
However, that doesn't mean it's easy to find. Many patients report difficulty locating Prasugrel at their local pharmacies, and this disconnect between official status and real-world experience is frustrating.
The reality is that Prasugrel exists in a gray area: there's enough supply in the overall system, but it's not evenly distributed to every pharmacy. This is sometimes called a "soft shortage" or "access gap" — the drug exists, but getting it into your hands can be a challenge.
Several factors contribute to the difficulty patients face when trying to fill their Prasugrel prescription:
Prasugrel is prescribed almost exclusively for patients who have undergone percutaneous coronary intervention (PCI) — having a stent placed. Unlike Clopidogrel, which is used for a broad range of cardiovascular conditions, Prasugrel serves a smaller patient population. Many pharmacies simply don't carry it because they rarely get prescriptions for it.
While generic Prasugrel is available, fewer companies manufacture it compared to high-volume generics. This means the supply chain has less redundancy. Any hiccup in production — even a temporary one — can create ripples that patients feel at the pharmacy counter.
Pharmaceutical distributors may allocate limited quantities of less-common medications to individual pharmacies. If your pharmacy can only order a small amount at a time, it may take longer to get your prescription filled.
For a deeper look at all the reasons behind these availability issues, read our post on why Prasugrel is so hard to find.
Cost is another factor that affects access. Here's what you can expect to pay for Prasugrel in 2026:
If cost is a barrier, check out our full guide on coupons, discounts, and patient assistance for Prasugrel.
The P2Y12 inhibitor landscape hasn't changed dramatically recently, but there are a few developments worth noting:
If you're having trouble finding Prasugrel, here are the most effective strategies:
For a detailed walkthrough, see our guide on how to find Prasugrel in stock near you.
While Prasugrel isn't in a formal shortage in 2026, the reality on the ground tells a different story for many patients. Limited demand, few manufacturers, and distribution quirks can make this critical heart medication surprisingly difficult to find at your local pharmacy.
The most important thing you can do is plan ahead. Don't wait until your last pill to request a refill. Use tools like Medfinder to find pharmacies with stock, explore savings programs to reduce cost barriers, and keep your cardiologist informed if you're having trouble.
Prasugrel is a lifesaving medication — and with the right approach, you can make sure you always have access to it. For information on possible drug interactions to discuss with your doctor, visit our post on Prasugrel drug interactions.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.